The effect of exercise and dark chocolate on combined factors in overweight women

The effect of the eighth week of combined exercise and consumption of dark chocolate on cardiovascular factors in overweight women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240804062639N1

Enrollment

Registered

2024-09-27

Start date

2024-08-17

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: overweight. Condition 2: Lactate dehydrogenase. Condition 3: C-reactive protein. Condition 4: Creatine phosphokinase. Condition 5: dark chocolate. Condition 6: combined training. Condition 7: Body mass index. Overweight and obesity Body mass index [BMI]

Interventions

Intervention 1: Control group: They do not receive any intervention. Intervention 2: First intervention group: Women in the dark chocolate group consume 20 grams of dark chocolate (4 pieces of 5 grams

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Willingness to cooperate Age range from 20 to 50 years overweight (body mass index 25-29.9 kg/m2) Absence of cardiovascular, lung, allergy, diabetes, liver-kidney failure and cancer Not having any physical injury and inability to perform the protocol of combined exercises Not taking any medicine or supplement during the last three months before the study No alcohol, smoking and tobacco use Not having any allergy to dark chocolate and its ingredients

Exclusion criteria

Exclusion criteria: Reluctance to consuming dark chocolate Pregnancy, breastfeeding and menopause Smoking and any therapeutic intervention affecting laboratory results Injury caused by sports training Allergy to dark chocolate Having any diseases and hormonal disorders Reluctance to participating in sports training

Design outcomes

Primary

Measure	Time frame
Lactate dehydrogenase enzyme. Timepoint: Measurement of lactate dehydrogenase enzyme 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and serum level of lactate dehydrogenase enzyme.;Reactive protein c. Timepoint: Measurement of reactive protein c 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and checking the serum level of reactive protein c.;Creatine phosphokinase enzyme. Timepoint: Measurement of creatine phosphokinase enzyme 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and serum level of creatine phosphokinase enzyme.	—

Measure

Time frame

Lactate dehydrogenase enzyme. Timepoint: Measurement of lactate dehydrogenase enzyme 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and serum level of lactate dehydrogenase enzyme.;Reactive protein c. Timepoint: Measurement of reactive protein c 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and checking the serum level of reactive protein c.;Creatine phosphokinase enzyme. Timepoint: Measurement of creatine phosphokinase enzyme 48 hours before intervention and 48 hours after the end of eight weeks of intervention. Method of measurement: Blood test and serum level of creatine phosphokinase enzyme.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegar Hajati

Islamic Azad University

hajati.n98@gmail.com+98 31 3786 4559

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026